For best experience please turn on javascript and use a modern browser!
Bekijk de site in het Nederlands

Because of the high incidence of chronic fibroproliferative disease and the related mortality, better understanding of the underlying mechanisms is needed in order to pursue better anti-fibrotic drugs that are both safe and effective in limiting and eliminating fibrotic disease without affecting normal healing of tissue. To obtain such insight, Jan Willem Duitman investigates the role of C/EBP and the protease activated receptors (PARs) during fibrotic disease.

Event details of Infectious diseases and fibrotic disorders
Date 16 May 2014
Time 14:00 -15:00
Location Agnietenkapel

J.W. Duitman, Infectious Diseases and Fibrotic Disorders: Potential Novel Targets.


Prof. S. Florquin
Prof. T. van der Poll


Dr C.A. Spek
Prof. M.P. Peppelenbosch


Oudezijds Voorburgwal 229 - 231
1012 EZ Amsterdam


This event is open to the public.